0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Uveitis - Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-012
Home | Market Reports | Health | Vision Care
Uveitis Epidemiology Forecast to 2028

Uveitis - Epidemiology Forecast to 2028

Code: DELV-Epid-012
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Uveitis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Uveitis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Uveitis Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Uveitis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Uveitis outlook. It also includes the explanation of changing trends of epidemiology outlining the Uveitis scenario.

Uveitis Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Uveitis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Uveitis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Uveitis Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Uveitis

Key assessments
• Patient Segmentation in Uveitis
• Uveitis Risk & Burden
• Factors driving growth in a specific Uveitis patient population

1. Report Introduction
2. Uveitis Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Uveitis in 2016
2.2. Patient Share Distribution of Uveitis in 2028
3. Disease Background and Overview: Uveitis
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Uveitis in 7MM
4.3. Total Prevalent/ Incident Patient Population of Uveitis in 7MM – By Countries
5. Epidemiology of Uveitis by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Uveitis
5.1.3. Sub-Type Specific cases of the Uveitis *
5.1.4. Sex- Specific Cases of the Uveitis *
5.1.5. Diagnosed Cases of the Uveitis
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Uveitis
5.4.3. Sub-Type Specific cases of the Uveitis *
5.4.4. Sex- Specific Cases of the Uveitis *
5.4.5. Diagnosed Cases of the Uveitis
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Uveitis
5.5.3. Sub-Type Specific cases of the Uveitis *
5.5.4. Sex- Specific Cases of the Uveitis *
5.5.5. Diagnosed Cases of the Uveitis
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Uveitis
5.6.3. Sub-Type Specific cases of the Uveitis *
5.6.4. Sex- Specific Cases of the Uveitis *
5.6.5. Diagnosed Cases of the Uveitis
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Uveitis
5.7.3. Sub-Type Specific cases of the Uveitis *
5.7.4. Sex- Specific Cases of the Uveitis *
5.7.5. Diagnosed Cases of the Uveitis
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Uveitis
5.8.3. Sub-Type Specific cases of the Uveitis *
5.8.4. Sex- Specific Cases of the Uveitis *
5.8.5. Diagnosed Cases of the Uveitis
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Uveitis
5.9.3. Sub-Type Specific cases of the Uveitis *
5.9.4. Sex- Specific Cases of the Uveitis *
5.9.5. Diagnosed Cases of the Uveitis
6. Unmet Needs of the Uveitis
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Uveitis in 7MM
Table 2: Total Prevalent/Incident Cases of the Uveitis in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Uveitis in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Uveitis in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Uveitis in United States (2016-2028)*
Table 6: Diagnosed Cases of the Uveitis in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Uveitis in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Uveitis in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Uveitis in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Uveitis in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Uveitis in France (2016-2028)
Table 12: Sub-Type Specific cases of the Uveitis in France (2016-2028) *
Table 13: Sex- Specific Cases of the Uveitis in France (2016-2028) *
Table 14: Diagnosed Cases of the Uveitis in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Uveitis in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Uveitis in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Uveitis in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Uveitis in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Uveitis in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Uveitis in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Uveitis in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Uveitis in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Uveitis in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Uveitis in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Uveitis in UK (2016-2028) *
Table 26: Diagnosed Cases of the Uveitis in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Uveitis in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Uveitis in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Uveitis in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Uveitis in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Uveitis in 7MM
Figure 2: Total Prevalent/Incident Cases of the Uveitis in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Uveitis in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Uveitis in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Uveitis in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Uveitis in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Uveitis in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Uveitis in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Uveitis in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Uveitis in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Uveitis in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Uveitis in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Uveitis in France (2016-2028) *
Figure 14: Diagnosed Cases of the Uveitis in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Uveitis in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Uveitis in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Uveitis in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Uveitis in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Uveitis in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Uveitis in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Uveitis in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Uveitis in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Uveitis in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Uveitis in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Uveitis in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Uveitis in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Uveitis in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Uveitis in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Uveitis in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Uveitis in Japan (2016-2028)

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Wearable Eye Tracker Market Insights Forecast to 2028
Global Wearable Eye Tracker Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-13A7619
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nepafenac Market Insights Forecast to 2028
Global Nepafenac Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18M7662
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Optometry Market Insights and Forecast to 2028
Global Optometry Market Insights and Forecast to 2028

Market Analysis and Insights Global Optometry MarketThe global Optometry market size is projected to reach US 79770 million by 2028 from US 63170 million in 2021 at a CAGR of 3.3 during 20222028.Fully considering the economic change by this health crisis Myopia accounting for of the Optometry global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-20F10207
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global FFP2 Grade Medical Protective Mask Market Insights and Forecast to 2028
Global FFP2 Grade Medical Protective Mask Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-3N8090
Tue May 03 00:00:00 UTC 2022

Add to Cart